Behrens, Annika
Fasching, Peter A.
Schwenke, Eva
Gass, Paul
Häberle, Lothar
Heindl, Felix
Heusinger, Katharina
Lotz, Laura
Lubrich, Hannah
Preuß, Caroline
Schneider, Michael O.
Schulz-Wendtland, Rüdiger
Stumpfe, Florian M.
Uder, Michael
Wunderle, Marius
Zahn, Anna L.
Hack, Carolin C.
Beckmann, Matthias W.
Emons, Julius
Funding for this research was provided by:
Friedrich-Alexander-Universität Erlangen-Nürnberg
Article History
Received: 5 April 2022
Accepted: 28 August 2023
First Online: 28 September 2023
Declarations
:
: The study was approved by the Ethics Committee of the medical faculty at Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany and was conducted under the 1975 Declaration of Helsinki. All patients provided written informed consent.
: Not applicable.
: P.A.F. received honoraria from Novartis, Pfizer, Roche, Amgen, Celgene, Daiichi-Sankyo, AstraZeneca, Merck-Sharp & Dohme, Eisai, Puma and Teva, his institution conducts research with funding from Novartis and Biontech. C.P. reports personal collaboration with AMOENA (consultancy work). C.C.H. has received honoraria from Roche, Pfizer, and Novartis. J.E. reports personal fees from Novartis, Pfizer and Eisai. All remaining authors have declared no competing interests.